Vanguard Health Care ETF (NY:VHT)

315.10 +3.20 (+1.03%)

Delayed Quote Updated: 3:17 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vanguard Health Care ETF

< Previous 1 2 3 4 5 Next >

Want to Buy the Dip on Eli Lilly? Consider This Low-Cost Vanguard ETF ↗

March 24, 2026

After nearly tripling between 2023 and the end of 2025, Lilly is undergoing a steep sell-off in 2026.

Via The Motley Fool

Topics ETFs

Why Did CRMD Stock Tumble Over 11% Today? ↗

March 05, 2026

The company reported mixed Q4 results with a revenue of $128.6 million and earnings per share of $0.16.

Via Stocktwits

Topics Artificial Intelligence

HELP Stock Tanks 22% Despite Strong Phase 2 Results For Anxiety Treatment: Retail Buys The Dip Ignoring Market’s Pessimism ↗

March 05, 2026

In the study, participants receiving a 20-milligram dose of HLP004 alongside standard-of-care treatment experienced an average drop of roughly 10.4 points on the Hamilton Anxiety Rating Scale after six...

Via Stocktwits

TLRY Stock Slumps 4%: What’s Driving The Selloff? ↗

March 02, 2026

Tilray said that it has acquired the BrewDog brand and related intellectual property, UK brewing operations and eleven strategic brewpubs in the United Kingdom and Ireland.

Via Stocktwits

Topics Cannabis Intellectual Property

Janux Stock Is Rising Pre-Market After A New Oncology Deal With Bristol Myers Squibb ↗

January 22, 2026

Via Stocktwits

BDSX Stock Shot Up 23% Pre-Market Today — What’s Fueling The Surge? ↗

January 12, 2026

Via Stocktwits

Why Is Tempus AI Stock Surging 11% Premarket Today? ↗

January 12, 2026

Via Stocktwits

Topics Artificial Intelligence

Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue ↗

February 26, 2026

The company generated $147 million in revenue during Q4, a 67% year-on-year (YoY) increase. Earnings per share (EPS) for the quarter were $0.11.

Via Stocktwits

Topics Artificial Intelligence

PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20 ↗

February 26, 2026

Bank of America reduced its rating on PROCEPT BioRobotics to ‘Underperform’ from ‘Neutral’.

Via Stocktwits

Topics Artificial Intelligence

XWEL Stock Soars 300%, Hits 200-DMA For First Time In Nearly Four Months – What Triggered The Rally? ↗

February 25, 2026

The company signed a securities purchase agreement with American Ventures on Tuesday as part of a private placement worth up to $31.3 million.

Via Stocktwits

Why Did CASI Stock Plummet 64% Today To Hit An All-Time Low? ↗

February 25, 2026

CASI stated the Nasdaq determined that the company had failed to satisfy the continued listing conditions to remain listed on the Nasdaq Stock Market.

Via Stocktwits

Why Did IXHL Stock Tank Over 32% Today? ↗

February 25, 2026

The company’s board approved a 1-for-30 reverse stock split, effective on February 26.

Via Stocktwits

EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious ↗

February 25, 2026

KeyBanc downgraded Evolent Health to ‘Sector Weight’ from ‘Overweight’, citing a lack of visibility in near-term EBITDA recovery.

Via Stocktwits

Why Did Larimar Therapeutics’ Stock Surge Over 30% Pre-Market Today? ↗

February 24, 2026

The FDA has granted Breakthrough Therapy Designation to Larimar’s frataxin protein replacement therapy, nomlabofusp.

Via Stocktwits

Why Did IOVA Stock Gain Pre-Market Today? ↗

February 24, 2026

The company announced encouraging early results from a pilot study evaluating its tumor-infiltrating lymphocyte therapy, lifileucel and reported strong fourth-quarter earnings.

Via Stocktwits

Why Did PVLA Stock Surge 45% In Pre-Market Today? ↗

February 24, 2026

The biotech company reported statistically significant Phase 3 data for QTORIN gel.

Via Stocktwits

Why Is GRAL Stock Down Today? Analysts Lower Targets After UK Trial Setback But Call Selloff Overdone ↗

February 20, 2026

Baird analyst Catherine Ramsey Schulte slashed the price target on Grail to $82 from $113 while reiterating an ‘Outperform’ rating.

Via Stocktwits

MLTX Stock Gains As Retail Eyes Buyout From Big Pharma, Upcoming Investor Day Event ↗

February 17, 2026

Some Stocktwits users voiced optimism for the inflammation-drug maker getting acquired by pharma giant Merck.

Via Stocktwits

Topics Intellectual Property

IBRX Stock Jumps 6% Pre-Market On BCG Update In Saudi Arabia – Retail Says Share Price Is ‘Attractive’ ↗

February 17, 2026

The Saudi Food and Drug Authority encouraged the company to submit a regulatory filing for its recombinant Bacillus Calmette-Guérin, which the company expects to submit within weeks.

Via Stocktwits

Why Did INTS Stock Plummet 30% Pre-Market Today? ↗

February 13, 2026

Intensity Therapeutics announced a 1-for-25 reverse stock split, consolidating every 25 existing shares into a single new share.

Via Stocktwits

NKTR Stock Soars After Nektar Reports Positive Atopic Dermatitis Trial Results ↗

February 10, 2026

Nektar announced positive results from the 36-week blinded maintenance period of the 52-week REZOLVE-AD study of its experimental drug, rezpegaldesleukin.

Via Stocktwits

HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge ↗

February 09, 2026

The company stated that its product, Symvess, is the only human-derived bioengineered blood vessel approved by the U.S. Food and Drug Administration.

Via Stocktwits

Why Did Healthcare Triangle Stock Plummet 20% Today? ↗

February 06, 2026

The technology firm announced that it will implement a 1-for-60 reverse stock split of its common shares effective at 12:01 a.m. Eastern Time on February 10.

Via Stocktwits

MDXG Stock Rises As MiMedx Enters Into Exclusive Distribution Agreement For Three Products ↗

February 04, 2026

According to the agreement, Summit Products Group will distribute Hydrelix, NovaForm, and G4Derm Plus, designed to complement MiMedx’s portfolio of leading surgical and wound products.

Via Stocktwits

Topics Artificial Intelligence

Why Did GUTS Stock Plummet Today Despite Positive Gut Therapy Midterm Study? ↗

January 29, 2026

Six-month data from 40 participants suggest that Revita helps limit weight regain after GLP-1 discontinuation.

Via Stocktwits

Why Did Glucotrack Stock Surge 12% Pre-Market Today? ↗

January 29, 2026

The company has received patents for its continuous blood glucose monitoring system.

Via Stocktwits

Topics Intellectual Property

INMD Stock Jumped Nearly 13% Today – What’s Powering The Rally? ↗

January 26, 2026

According to a Calcalist report, the company is set to go private after a $1.1 billion acquisition by a fund.

Via Stocktwits

Topics Artificial Intelligence

Why Did Corcept Therapeutics Stock Surge Over 14% Today? ↗

January 22, 2026

In the ROSELLA trial, patients receiving relacorilant with nab-paclitaxel saw their risk of death drop by about 35% compared with those given the chemotherapy alone.

Via Stocktwits

This Is My No. 1 Recommended Vanguard ETF to Buy in 2026 ↗

January 18, 2026

The stars could be aligning for healthcare stocks this year. This Vanguard ETF is a great way to play it.

Via The Motley Fool

Topics ETFs Economy

Retail Traders Are Piling Into TG Therapeutics – What’s Driving The Chatter? ↗

January 14, 2026

On Tuesday, the company provided the revenue outlook for 2026 and fourth-quarter (Q4) and fiscal year 2025 revenue projection for BRIUMVI.

Via Stocktwits

Topics Artificial Intelligence

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.